Neuroprotection by Acetyl-L-Carnitine after Traumatic Injury to the Immature Rat Brain
- 1 January 2010
- journal article
- research article
- Published by S. Karger AG in Developmental Neuroscience
- Vol. 32 (5-6), 480-487
- https://doi.org/10.1159/000323178
Abstract
Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in children and is characterized by reduced aerobic cerebral energy metabolism early after injury, possibly due to impaired activity of the pyruvate dehydrogenase complex. Exogenous acetyl-L-carnitine (ALCAR) is metabolized in the brain to acetyl coenzyme A and subsequently enters the tricarboxylic acid cycle. ALCAR administration is neuroprotective in animal models of cerebral ischemia and spinal cord injury, but has not been tested for TBI. This study tested the hypothesis that treatment with ALCAR during the first 24 h following TBI in immature rats improves neurologic outcome and reduces cortical lesion volume. Postnatal day 21–22 male rats were isoflurane anesthetized and used in a controlled cortical impact model of TBI to the left parietal cortex. At 1, 4, 12 and 23 h after injury, rats received ALCAR (100 mg/kg, intraperitoneally) or drug vehicle (normal saline). On days 3–7 after surgery, behavior was assessed using beam walking and novel object recognition tests. On day 7, rats were transcardially perfused and brains were harvested for histological assessment of cortical lesion volume, using stereology. Injured animals displayed a significant increase in foot slips compared to sham-operated rats (6 ± 1 SEM vs. 2 ± 0.2 on day 3 after trauma; n = 7; p < 0.05). The ALCAR-treated rats were not different from shams and had fewer foot slips compared to vehicle-treated animals (2 ± 0.4; n = 7; p< 0.05). The frequency of investigating a novel object for saline-treated TBI animals was reduced compared to shams (45 ± 5% vs. 65 ± 10%; n = 7; p < 0.05), whereas the frequency of investigation for TBI rats treated with ALCAR was not significantly different from that of shams but significantly higher than that of saline-treated TBI rats (68 ± 7; p < 0.05). The left parietal cortical lesion volume, expressed as a percentage of the volume of tissue in the right hemisphere, was significantly smaller in ALCAR-treated than in vehicle-treated TBI rats (14 ± 5% vs. 28 ± 6%; p < 0.05). We conclude that treatment with ALCAR during the first 24 h after TBI improves behavioral outcomes and reduces brain lesion volume in immature rats within the first 7 days after injury.Keywords
This publication has 66 references indexed in Scilit:
- Lipid Peroxidation-Derived Reactive Aldehydes Directly and Differentially Impair Spinal Cord and Brain Mitochondrial FunctionJournal of Neurotrauma, 2010
- Acetyl‐l‐carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injuryJournal of Neurochemistry, 2010
- Early Nonischemic Oxidative Metabolic Dysfunction Leads to Chronic Brain Atrophy in Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2009
- Ontogeny of Rat Recognition Memory measured by the novel object recognition taskDevelopmental Psychobiology, 2009
- Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injuryExperimental Neurology, 2009
- Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young ratsJournal of Neurochemistry, 2009
- The Effects of a Ketogenic Diet on Behavioral Outcome after Controlled Cortical Impact Injury in the Juvenile and Adult RatJournal of Neurotrauma, 2009
- Recognition memory and the medial temporal lobe: a new perspectiveNature Reviews Neuroscience, 2007
- Cerebral Metabolic Adaptation and Ketone Metabolism after Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2007
- Postischemic hyperoxia reduces hippocampal pyruvate dehydrogenase activityFree Radical Biology & Medicine, 2006